| UniProt ID | 2A5A_HUMAN | |
|---|---|---|
| UniProt AC | Q15172 | |
| Protein Name | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform | |
| Gene Name | PPP2R5A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 486 | |
| Subcellular Localization | Cytoplasm . Nucleus . Chromosome, centromere . From mitotic prophase to metaphase, localizes at the inner centromere between a pair of sister kinetochores. Decreased expression at the onset of anaphase. | |
| Protein Description | The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment.. | |
| Protein Sequence | MSSSSPPAGAASAAISASEKVDGFTRKSVRKAQRQKRSQGSSQFRSQGSQAELHPLPQLKDATSNEQQELFCQKLQQCCILFDFMDSVSDLKSKEIKRATLNELVEYVSTNRGVIVESAYSDIVKMISANIFRTLPPSDNPDFDPEEDEPTLEASWPHIQLVYEFFLRFLESPDFQPSIAKRYIDQKFVQQLLELFDSEDPRERDFLKTVLHRIYGKFLGLRAFIRKQINNIFLRFIYETEHFNGVAELLEILGSIINGFALPLKAEHKQFLMKVLIPMHTAKGLALFHAQLAYCVVQFLEKDTTLTEPVIRGLLKFWPKTCSQKEVMFLGEIEEILDVIEPTQFKKIEEPLFKQISKCVSSSHFQVAERALYFWNNEYILSLIEENIDKILPIMFASLYKISKEHWNPTIVALVYNVLKTLMEMNGKLFDDLTSSYKAERQREKKKELEREELWKKLEELKLKKALEKQNSAYNMHSILSNTSAE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSSSSPPAG ------CCCCCCCCH | 38.64 | 25850435 | |
| 2 | Acetylation | ------MSSSSPPAG ------CCCCCCCCH | 38.64 | 22223895 | |
| 3 | Phosphorylation | -----MSSSSPPAGA -----CCCCCCCCHH | 33.27 | 25850435 | |
| 4 | Phosphorylation | ----MSSSSPPAGAA ----CCCCCCCCHHH | 39.29 | 25850435 | |
| 5 | Phosphorylation | ---MSSSSPPAGAAS ---CCCCCCCCHHHH | 36.53 | 25850435 | |
| 12 | Phosphorylation | SPPAGAASAAISASE CCCCHHHHHHHHHHH | 20.07 | 25850435 | |
| 16 | Phosphorylation | GAASAAISASEKVDG HHHHHHHHHHHHCCC | 22.48 | 28270605 | |
| 18 | Phosphorylation | ASAAISASEKVDGFT HHHHHHHHHHCCCCC | 31.03 | 28270605 | |
| 25 | Phosphorylation | SEKVDGFTRKSVRKA HHHCCCCCHHHHHHH | 42.59 | 24719451 | |
| 28 | Phosphorylation | VDGFTRKSVRKAQRQ CCCCCHHHHHHHHHH | 24.70 | 22817900 | |
| 38 | Phosphorylation | KAQRQKRSQGSSQFR HHHHHHHHCCCHHHH | 46.02 | 25159151 | |
| 41 | Phosphorylation | RQKRSQGSSQFRSQG HHHHHCCCHHHHHCC | 17.21 | 26846344 | |
| 42 | Phosphorylation | QKRSQGSSQFRSQGS HHHHCCCHHHHHCCC | 39.91 | 26846344 | |
| 46 | Phosphorylation | QGSSQFRSQGSQAEL CCCHHHHHCCCCCEE | 39.93 | 25159151 | |
| 49 | Phosphorylation | SQFRSQGSQAELHPL HHHHHCCCCCEECCC | 20.69 | 25159151 | |
| 100 | Phosphorylation | SKEIKRATLNELVEY CHHHHHHHHHHHHHH | 33.86 | 26074081 | |
| 107 | Phosphorylation | TLNELVEYVSTNRGV HHHHHHHHHHCCCCE | 7.69 | 26074081 | |
| 109 | Phosphorylation | NELVEYVSTNRGVIV HHHHHHHHCCCCEEE | 21.04 | 26074081 | |
| 110 | Phosphorylation | ELVEYVSTNRGVIVE HHHHHHHCCCCEEEC | 20.92 | 26074081 | |
| 118 | Phosphorylation | NRGVIVESAYSDIVK CCCEEECCHHHHHHH | 22.93 | 26074081 | |
| 120 | Phosphorylation | GVIVESAYSDIVKMI CEEECCHHHHHHHHH | 19.02 | 26074081 | |
| 121 | Phosphorylation | VIVESAYSDIVKMIS EEECCHHHHHHHHHH | 22.15 | 26074081 | |
| 181 | Malonylation | DFQPSIAKRYIDQKF CCCHHHHHHHCCHHH | 44.03 | 26320211 | |
| 181 | Acetylation | DFQPSIAKRYIDQKF CCCHHHHHHHCCHHH | 44.03 | 25953088 | |
| 217 | Ubiquitination | VLHRIYGKFLGLRAF HHHHHHHHHHCHHHH | 22.05 | - | |
| 259 | Ubiquitination | ILGSIINGFALPLKA HHHHHHHCCCCCCCH | 9.97 | 21890473 | |
| 263 | Ubiquitination | IINGFALPLKAEHKQ HHHCCCCCCCHHHHH | 28.52 | 22817900 | |
| 281 | Phosphorylation | KVLIPMHTAKGLALF HHHHHHHHHHHHHHH | 24.66 | 26434552 | |
| 316 | Ubiquitination | PVIRGLLKFWPKTCS HHHHHHHHHCCCCCC | 50.88 | 21890473 | |
| 316 | Ubiquitination | PVIRGLLKFWPKTCS HHHHHHHHHCCCCCC | 50.88 | 21890473 | |
| 320 | Ubiquitination | GLLKFWPKTCSQKEV HHHHHCCCCCCCHHE | 53.40 | 22817900 | |
| 361 | Phosphorylation | KQISKCVSSSHFQVA HHHHHHCCCHHHHHH | 35.28 | 29083192 | |
| 362 | Phosphorylation | QISKCVSSSHFQVAE HHHHHCCCHHHHHHH | 13.87 | 29083192 | |
| 363 | Phosphorylation | ISKCVSSSHFQVAER HHHHCCCHHHHHHHH | 22.33 | 29083192 | |
| 381 | Ubiquitination | FWNNEYILSLIEENI HHCCHHHHHHHHHCH | 3.14 | 29967540 | |
| 412 | Ubiquitination | EHWNPTIVALVYNVL HHCCHHHHHHHHHHH | 3.56 | 29967540 | |
| 421 | Phosphorylation | LVYNVLKTLMEMNGK HHHHHHHHHHHHCCH | 27.46 | 24719451 | |
| 438 | Ubiquitination | DDLTSSYKAERQREK HHHHHHHHHHHHHHH | 45.80 | 29967540 | |
| 457 | Ubiquitination | EREELWKKLEELKLK HHHHHHHHHHHHHHH | 49.93 | - | |
| 469 | Ubiquitination | KLKKALEKQNSAYNM HHHHHHHHCCCCHHH | 56.48 | 29967540 | |
| 472 | Phosphorylation | KALEKQNSAYNMHSI HHHHHCCCCHHHHHH | 29.63 | 20068231 | |
| 474 | Phosphorylation | LEKQNSAYNMHSILS HHHCCCCHHHHHHHH | 16.91 | 20068231 | |
| 478 | Phosphorylation | NSAYNMHSILSNTSA CCCHHHHHHHHCCCC | 17.92 | 25159151 | |
| 481 | Phosphorylation | YNMHSILSNTSAE-- HHHHHHHHCCCCC-- | 36.07 | 20068231 | |
| 484 | Phosphorylation | HSILSNTSAE----- HHHHHCCCCC----- | 34.35 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 2A5A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 2A5A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| 2A5G_HUMAN | PPP2R5C | physical | 11929880 | |
| 2AAA_HUMAN | PPP2R1A | physical | 18782753 | |
| PP2AA_HUMAN | PPP2CA | physical | 18782753 | |
| 2AAB_HUMAN | PPP2R1B | physical | 18782753 | |
| AXIN1_HUMAN | AXIN1 | physical | 11297546 | |
| PP2AA_HUMAN | PPP2CA | physical | 8703017 | |
| 2AAB_HUMAN | PPP2R1B | physical | 8703017 | |
| CCNG1_MOUSE | Ccng1 | physical | 11983168 | |
| PTTG1_HUMAN | PTTG1 | physical | 24781523 | |
| DAPK1_HUMAN | DAPK1 | physical | 20220139 | |
| PP2AA_HUMAN | PPP2CA | physical | 20220139 | |
| 2AAA_HUMAN | PPP2R1A | physical | 20220139 | |
| 2ABD_HUMAN | PPP2R2D | physical | 20220139 | |
| 2A5D_HUMAN | PPP2R5D | physical | 26344197 | |
| PP2AA_HUMAN | PPP2CA | physical | 26811472 | |
| BUB1B_HUMAN | BUB1B | physical | 26811472 | |
| CDC20_HUMAN | CDC20 | physical | 26811472 | |
| UBE2S_HUMAN | UBE2S | physical | 26811472 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 AND SER-42, AND MASSSPECTROMETRY. | |